PTHS
Pelthos Therapeutics Inc.
8.00$
-14.4%
vs. previous close
Closing price · As of: Nov 12, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Pelthos Therapeutics Inc. (PTHS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 11/12/2026 | Current report (8-K) | Pelthos Therapeutics Inc. (PTHS): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 10/30/2026 | Current report (8-K) | Pelthos Therapeutics Inc. (PTHS): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fisc | View report ↗ |
| 10/01/2026 | Current report (8-K) | Pelthos Therapeutics Inc. (PTHS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 08/13/2026 | Current report (8-K) | Pelthos Therapeutics Inc. (PTHS): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/13/2026 | Current report (8-K) | Pelthos Therapeutics Inc. (PTHS): Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.